SCHEMBL21973752

SCHEMBL21973752

c1ccc(-n2c3ccccc3c3cc(-c4cc(-c5cc(-c6cccnc6)nc(-c6cccnc6)c5)cc(-c5cc(-c6cccnc6)nc(-c6cccnc6)c5)c4)ccc32)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.56
KDM4E B2RXH2 2/20 0.43
DHODH Q02127 1/20 0.43
ATM Q13315 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MAPT P10636 3/20 0.42
CYP2C9 P11712 3/20 0.40
CYP1A2 P05177 1/20 0.40
POLB P06746 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
CYP11B1 P15538 3/20 0.40
CYP11B2 P19099 2/20 0.40
CYP17A1 P05093 1/20 0.40
MDM2 Q00987 1/20 0.39
G6PD P11413 1/20 0.39
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
KMT2A Q03164 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23843598 0.93 CYP19A1 (0.48) CYP19A1KDM4EDHODHATML3MBTL1
SCHEMBL21973746 0.90 CYP19A1 (0.61) CYP19A1KDM4EDHODHATML3MBTL1
SCHEMBL24493057 0.90 L3MBTL1 (0.47) CYP19A1KDM4EATML3MBTL1MAPT
SCHEMBL15369839 0.90 CYP19A1 (0.56) CYP19A1DHODHMAPTCYP2C9CYP1A2
SCHEMBL19654644 0.89 CYP19A1 (0.57) CYP19A1KDM4EDHODHATML3MBTL1
SCHEMBL15369824 0.89 CYP19A1 (0.54) CYP19A1KDM4EDHODHMAPTCYP2C9
SCHEMBL21973897 0.89 L3MBTL1 (0.51) CYP19A1KDM4EDHODHATML3MBTL1
SCHEMBL23057379 0.89 L3MBTL1 (0.51) CYP19A1KDM4EDHODHATML3MBTL1
SCHEMBL12162422 0.89 L3MBTL1 (0.51) CYP19A1KDM4EDHODHATML3MBTL1
SCHEMBL18560751 0.88 MAPT (0.45) CYP19A1KDM4EDHODHATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200140416-A1 COMPOUND, OLED DISPLAY PANEL AND ELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2020-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200140416-A1 COMPOUND, OLED DISPLAY PANEL AND ELECTRONIC DEVICE OCIAD2, OCIAD1, EED CYP19A1 727/4885KDM4E 2113/4885DHODH 1357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.